Further elucidating the mechanisms underlying the impairment of cancer progression by tumor microenvironment cells harboring a tumor suppressor genes in the haploinsufficient state, such as NF1+/−, may translate into novel therapeutic strategies. This evidence concerns the gene NF1 and neoplasm.